Page 413 - ILAE_Lectures_2015

12. MUSUMECI, S.A., FERRI, R., ELIA, M. et al (1991) Epilepsy and Fragile X syndrome: a follow-up study. Am.
J. Med. Genet. 38, 511-513.

13. MUSUMECI, S.A., FERRI, R. and BERGONZI, P. (1990) The specificity of the characteristic sleep EEG pattern
in the Fragile X syndrome. J. Neurol. 237, 64-66.

14. MATSUMOTO, A., KUMAGAI, T., MIURA, K. et al (1992) Epilepsy in Angelman syndrome associated with
chromosome 15q deletion. Epilepsia 33(6), 1083-1090.

15. HAUSER, W.A., SHINNARD, S., COHEN, H. et al (1987) Clinical predictors of epilepsy among children with
cerebral palsy and/or mental retardation. Neurology. 37 (Suppl. 1), 150.

16. SUSSOVA, J., SEIDL, Z. and FABER, J. (1990) Hemiparetic forms of cerebral palsy in relation to epilepsy and
mental retardation. Dev. Med. Child Neurol. 32, 792-795.

17. EDWARDS, J.G. and WHEAL, H.V. (1992) Assessment of epileptogenic potential: experimental, clinical and
epidemiological approaches. J. Psychopharmacol. 6(2), 204-213.

18. CLARKE, D.J., KELLEY, S., THINN, K. et al (1990) Psychotropic drugs and mental retardation: 1. Disabilities
and the prescription of drugs for behavior and for epilepsy in three residential settings. Ment. Defic. Res. 34, 385-
395.

19. BURFORD, B. (1990) Moving in sympathy: finding optimal skills for communicating with children and young
people with profound multiple handicaps. Research Report (Unpublished), University of Edinburgh, Edinburgh.

20. KERR, M.P., EVANS, S., NOLAN, M. et al (1995) Assessing clinicians’ consultation with people with profound
learning disability: producing a rating scale. J. Intellectual Disab. Res. 39, 187-190.

21. POINDEXTER, A.R., BERGLUND, J.A. and KOLSTOE, P.D. (1993) Changes in antiepileptic drug prescribing
patterns in large institutions: preliminary results of a five year experience. Am. J. Ment. Retardation 98 (Suppl.),
34-40.

22. PELLOCK, J. and HUNT, P. (1996) A decade of modern epilepsy therapy in institutionalized mentally retarded
patients. Epilepsy Res. 25, 263-268.

23. SINGH, B. and TOWLE, P. (1993) Antiepileptic drug status in adult outpatients with mental retardation. Am. J.
Ment. Retardation 98 (Suppl.), 41-46.

24. TOBIAS, E.S., BRODIE, A.F. and BRODIE, M.J. (1994) An outcome audit at the epilepsy clinic: results from
1000 consecutive patients. Seizure. 3, 37-43.

25. FISCHBACHER, E. (1982) Effects of reduction of anticonvulsants on well-being. Br. Med. J. Clin. Res. 285, 423-
424

26. BEGHI, E., BOLLINI, P., DI MASCHIO, R. et al (1987) Effects of rationalizing drug treatment of patients with
epilepsy and mental retardation. Dev. Med. Child Neurol 29 (3), 363-369

27. COLLACOTT, R.A., DIGNON, A., HAUK, A. et al (1989) Clinical and therapeutic monitoring of epilepsy in a
mental handicap unit. Br. J. Psychiatry 155, 522-525.

28. ALVAREZ N. (1989) Discontinuance of antiepileptic medications in patients with developmental disability and
a diagnosis of epilepsy. Am. J. Ment. Retardation 93 (6), 593-599.

29. PITKANEN, A., RUUTIAINEN, T., MERVAALA, E. et al (1989) Vigabatrin in epilepsy in mentally retarded
patients. Br. J. Clin. Pharmacol. 27 ( Suppl 1), S113-118.

30. PITKANEN, A., YLINEN, A., MATILAINEN, R. et al (1993) Long-term anti-epileptic efficacy of vigabatrin in
drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. Arch. Neurol. 50(1), 24-29.

31. BUCHANAN, N. (1996) The efficacy of lamotrigine on seizure control in 34 children, adolescents and young

adults with intellectual and physical disability. In: Lamotrigine  A Brighter Future (Ed. P. Loiseau), pp. 89-102.
International Congress and Symposium Series, No 24. Royal Society of Medicine, London.
32. CHIRON, C., DULAC, O., BEAUMONT, D. et al (1991) Therapeutic trial of vigabatrin in refractory infantile
spasms. J. Child Neurol. 6 (Suppl. 2), 52-59.
33. APPLETON, R. and THORNTON, L. (for the Infantile Spasm Study Group) (1996) Double-blind comparison of
vigabatrin versus placebo in newly diagnosed and previously untreated infantile spasms. Epilepsia 37 (Suppl. 5),
125.
34. TREVATHAN, E., MOTTE, J., ARVIDSSON, J. et al (1996) Safety and tolerability of adjunctive Lamictal for
the treatment of Lennox-Gastaut syndrome: results of a multinational, double-blind, placebo-controlled trial.
Epilepsia (Suppl. 5), 202.
35. KERR, M.P., BAKER G.A., BRODIE, M.J. (2005) A randomised, double-blind, placebo-controlled trial of
topiramate in adults with epilepsy and intellectual disability: Impact on seizure, severity and quality of life.
Epilepsy Behav. 7, 472-480.
36. KELLY, K., STEPHEN, L. and BRODIE, M,J. (2004) Levetiracetam for people with mental retardation and
refractory epilepsy. Epilepsy Behav. 5, 878-883.
37. GLAUSER, T., KLUGER, G., SACHDEO, R. et al (2008) Rufinamide for generalised seizures associated with
Lennox-Gastaut syndrome. Neurology; 70: 1-9.